Chemical Biology lab @HarvardMed and @DanaFarber. We use a multidisciplinary approach to study biological roles of epigenetic proteins & transcription factors.
Our collaborative work with @IrenemGhobrial on targeting transcription factor IRF4 is now online @nchembio. It is so exciting that we discovered an IRF4 binder & a selective IRF4 degrader that can interrupt MM cell growth. Congrats @10mM_Mike & all authors rdcu.be/flcIs
Our collaborative study with Dr. Qiong Duan on histone acetylation regulated energy storage is now published @MolMetab. We established more understanding on how "active" acetylation vs "passive" acetylation balanced each other at different states. molecularmetabolism.com/arti…
Hope is powerful. Research is lifesaving. 🙏
Your support helps fund groundbreaking discoveries for children battling cancer.
Read how it’s making a difference in our latest edition of Research Outcomes: ow.ly/sNel50YhTUk
With better understanding of proteosome machinery, hopefully, we can come up more and more cool idea to utilize the system for novel therapy development.
New research in @angew_chem by @DanaFarber’s @JunQiLab reveals a novel chemical biology approach to achieving selective targeted protein degradation using proteosome cap region proteins directly in addition to the current PROTAC strategy, which could aid in developing therapies and cancer drugs.
➡️ bit.ly/4rbilu9
It was such a fun day to visit @PennMedicine and talk about science with @junwei_s @LilingWanLab and present our science. Thank you for having me.
Our work using cap region proteins of proteosome to directly induce targeted protein degradation is now published online @angew_chem. Congratulations to all the authors on bringing this to the finish line. Thanks @BloodCancerUtd for supporting our work.
doi.org/10.1002/anie.2025200…
We would like to thank the support from @EpendymomaRF, @curingkidsckc and @StBaldricks that allow us to build our biology capability to explore novel therapeutic options for pediatric brain cancer.
I am thrilled to work and publish together with my postdoc PI, Prof. Mo Movassaghi @ChemistryMIT to bring their sophisticated chemistry to potential therapy development. I am excited to keep learning from Mo and @FilbinMariella. Pic from: news.mit.edu
This is absolutely fun!!! @LabSethi cannot wait to do more together. To create more and better understanding in cancers and find potential novel therapy together. @AGA_Gastro
Can we have a biotinylated and inactive version of the HDAC1/2 inhibitor? How do you do Chem-seq, Jun? In the end, we were able to follow our observations and publish these findings thanks to collaborative science fostered by @DanaFarber@DanaFarberNews
It is so exciting to see the final version of our collaborative work with @LabSethi. We found that blocking HDAC1/2 pushes CRC cells out of a stem-like state and into differentiation. We will work tother more to find novel therapeutic options for CRC. authors.elsevier.com/c/1m7oK…
It is so exciting to see our collaborative work with @Nilay_Sethi is now available online. My team and I are always eager to learn more about novel therapy development for CRC together with Nilay and his wonderful team!!!
Proof-of-concept: Epigenetic reprogramming could one day be a new therapeutic path in colorectal cancer. @Nilay_Sethi explains how histone acetylation shapes CRC cell fate in this @AGA_Gastro study: bit.ly/46gS7z1
It is awesome to have JQ-WON team to build a boat and get first place in the boat building competition at @DFCI_ChemBio retreat!!!! Awesome design, decoration, ride, and teamwork!
Had a great time visiting Dana-Farber Cancer Institute and sharing our work on chromatin mechanisms in cancer! Huge thanks to @JunQiLab for the invitation and generous hosting. So much fun reconnecting with mentor & old friends, making new ones, & a full day of amazing science!
It is so exciting to receive the Curing Kids Cancer Research Award from @curingcancer together with our dearest collaborators, @ADurbinLab@RousselMartine! Thank you for supporting our work to develop a novel therapeutic strategy for medulloblastoma!
It is great to celebrate this holiday season with a group of hardworking and self motivated lab members. Thank you for making the science so much fun. I am excited to work with you more in 2025. Happy holidays, Qi lab!!!!!
It is also exciting to see that the Chem-Seq works so well with HDAC1/2 with @Nilay_Sethi and @LabSethi after the development on Chem-Seq of BET bromodomain @jaybradner.
biorxiv.org/content/10.1101/…. Aberrations in epigenetic regulation prevent cellular differentiation and endow plasticity to cancer. By screening drugs using a new reporter system, we found that inhibiting HDAC1/2 promotes colorectal cancer (CRC) differentiation and anti-tumor activity
biorxiv.org/content/10.1101/…. Aberrations in epigenetic regulation prevent cellular differentiation and endow plasticity to cancer. By screening drugs using a new reporter system, we found that inhibiting HDAC1/2 promotes colorectal cancer (CRC) differentiation and anti-tumor activity